Memphasys (MEM) News Today → AI to Meet the Same Fate as EVs? (From Porter & Company) (Ad) Free MEM Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMemphasys Reaches AU$20m Market Cap Benefiting Insider Stock Buyinghk.finance.yahoo.com - May 22 at 12:13 AMMemphasys Reaches AU$20m Market Cap Benefiting Insider Stock Buying \finance.yahoo.com - May 20 at 7:23 PMBlood pressure rises at Aegros, the next plasma hopefulafr.com - April 5 at 3:16 PMDr Boreham’s Crucible: Every sperm is sacred – and profitablemsn.com - April 2 at 6:35 PMMemphasys Limited (IG7.F)finance.yahoo.com - March 9 at 10:54 PMMemphasys First Half 2023 Earnings: AU$0.001 loss per share (vs AU$0.001 loss in 1H 2022)finance.yahoo.com - February 25 at 10:46 PMResearch Insight View on Centrifugation-free Sperm Separation Systems Market Size [2023-2028] | Emerging Trend and Current Developmentsmarketwatch.com - February 23 at 3:39 PMASX Health Stocks: Creso eyes psychedelic spinout off the back of landmark TGA decisionmsn.com - February 6 at 9:18 PMA Memphasys Limited (ASX:MEM) insider increased their holdings by 6.2% last yearfinance.yahoo.com - December 11 at 9:42 PMPlacement outbreak: Creso Pharma, New World, Memphasys chase investorsafr.com - July 27 at 2:35 AMASX Health Stocks: Neurotech says its cannabis strain works well when combined with Diclofenacmsn.com - June 9 at 2:36 AMMemphasys achieves quality certification for medical devices and diagnosticsproactiveinvestors.com.au - March 20 at 11:27 PMMemphasys outlines vision for biological separation tech in 2022proactiveinvestors.com.au - January 26 at 9:16 PMStandouts: 3 ASX biotech shares that outperformed in Novembermsn.com - December 8 at 11:16 PMMemphasys Limited (MEM.AX)au.finance.yahoo.com - December 7 at 8:13 PMThese 3 ASX healthcare shares are soaring today. Why?msn.com - November 16 at 6:37 AMASX Health Stocks: Paradigm rockets 21pc after getting FDA nod, Memphasys up 31pc on imminent launchmsn.com - November 2 at 10:06 PMEllume is making news and these ASX shares are surging, againfool.com.au - July 29 at 7:50 PMWhen Ellume is making news, these ASX shares are in focusmsn.com - July 28 at 12:17 AM Get Memphasys News Delivered to You Automatically Sign up to receive the latest news and ratings for MEM and its competitors with MarketBeat's FREE daily newsletter. Email Address Investors Alert: The Next Big Thing in Weight Loss (Ad)History shows biotech breakthroughs like this can turn small investments into staggering fortunes for those with the foresight to get in early. I've isolated the small company behind it all... The profit window is closing - don't get left behind! MEM Media Mentions By Week MEM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MEM News Sentiment▼0.000.61▲Average Medical News Sentiment MEM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MEM Articles This Week▼00▲MEM Articles Average Week Get Memphasys News Delivered to You Automatically Sign up to receive the latest news and ratings for MEM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AGNPF News AKBLF News DRTSW News ARNI News ARTLW News ASCLF News AVCTF News AWKNF News AXIM News BRRGF News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:MEM) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryMost important medical advance in 100 yearsThe Oxford ClubFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Memphasys Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.